Global Pharmatech, Inc.
GBLP · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $62 | $95 | $57 | $72 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $62 | $95 | $57 | $72 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 368.4% | 13.3% | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 11.1% | 66% | 50.2% | – |
| EBITDA | -$0 | $0 | $0 | -$0 |
| % Margin | -19.3% | 44.8% | 354.3% | – |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -21.8% | -208.7% | -35.9% | – |
| EPS Diluted | -0 | -0 | -0 | -0 |
| % Growth | 50% | -300% | 75% | – |
| Operating Cash Flow | $0 | -$0 | $0 | -$0 |
| Capital Expenditures | -$0 | $0 | -$0 | $0 |
| Free Cash Flow | $0 | $0 | $0 | -$0 |